Loading...
Last update:  March 8, 2020
12:20 +1GMT

Allergenic Molecule  Asp f 6Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2014Korea, Republic ofIgE2516.00020140821, Choi JS
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE993.03020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE962.08020120528, Patelis A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8618.60020101214, Gadisseur R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010FranceIgE1758.82020100715, Fricker-Hidalgo H
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70220090826, Ebo DG
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE229.09020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE205.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2050.00020091005, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007GermanyIgE850.00020070305, RingerS
3.1.2 - Source Sensitized - High Exposure (SPT)2003SwitzerlandIgE875.0002003, Casaulta C
3.1.3 - Source Sensitized - Low Exposure (SPT)2003SwitzerlandIgE757.1002003, Casaulta C
5.1.1 - Source Exposed (Symptoms)2002United StatesIgE1827.8002002, McCann WA
4.1.5 - Heterologous Source Sensitized (IgE)2001United StatesIgE650.0002001, Wagner S
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000SwitzerlandIgE2458.0002000a, Kurup VP
3.1.4 - Source Sensitized (SPT, IgE)2000SwitzerlandIgE160.0002000a, Kurup VP
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1998SwitzerlandIgE5453.6001998, Crameri R
3.1.4 - Source Sensitized (SPT, IgE)1998SwitzerlandIgE350.0001998, Crameri R
Developed by
Panservice